Bioglan Curcumin + Pain Relief

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Piper nigrum, Quantity: 2.5 mg (Equivalent: Piper nigrum, Qty 51.25 mg); Boswellia serrata, Quantity: 308 mg (Equivalent: Boswellia serrata, Qty 1.23 g; Equivalent: boswellic acid, Qty 200.2 mg); Zingiber officinale, Quantity: 100 mg (Equivalent: Zingiber officinale, Qty 1 g; Equivalent: Gingerols calculated as gingerol-[6], Qty 11 mg); Curcuma longa, Quantity: 632 mg (Equivalent: Curcuma longa, Qty 15.8 g; Equivalent: curcuminoids (of Curcuma longa), Qty 600 mg)

Available from:

Natural Bio Pty Limited

INN (International Name):

Boswellia serrata,Curcuma longa,Piper nigrum,Zingiber officinale

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: Carnauba Wax; maltodextrin; curcumin; magnesium stearate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; macrogol 400; hypromellose; colloidal anhydrous silica; povidone; croscarmellose sodium

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support general health and wellbeing ; Anti-inflammatory/relieve inflammation ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis (Linked Indication:Decrease/reduce/relieve mild joint inflammation/swelling; Decrease/reduce/relieve mild joint pain/soreness; Decrease/reduce/relieve mild joint stiffness); Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Maintain/support joint health

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2016-07-22